COMMENTARY

• Transfer Limited Financial Resources to Parties Who Make Effort to Provide Better Services
  March 1, 2010

• Korosho Moves to Change Its Vaccine Policy
  February 22, 2010

• Prospects of the Japanese Pharmaceutical Industry in 2010
  February 15, 2010

• Number of Entrants into Market for Biosimilars Increases, But Barriers Are Still High
  February 8, 2010

• New Pricing System to Make e-Detailing More Important
  February 1, 2010

• Number of Holders of Designated Disease Treatment Beneficiary Certificate Up to 647,604
  November 30, 2009

• Verify Acceptability of Prices before Revising Pricing Rule
  November 30, 2009

• Pharmacology of Aging and Longevity: Looking for Anti-Aging Therapeutics （２）
  November 2, 2009

• Pharmacology of Aging and Longevity: Looking for Anti-Aging Therapeutics （１）
  November 2, 2009

• How Not to License a Drug into Japan
  October 12, 2009

• TOPICS／Abbott Named One of the "Best Places to Launch a Career" by BusinessWeek
  October 5, 2009

• NHI Drug Pricing System Reform Becomes Further Unpredictable Following Gov't Change
  October 5, 2009

• COMMENTARY／Pharma Industry Watches New DPJ Administration with Both Anticipation and Concerns
  September 21, 2009

• COMMENTARY／Will It Be Possible to Eliminate Use of Multiple Antipsychotics in Massive Doses?
  September 14, 2009

• COMMENTARY／Establish Solid Criteria for Switching Ethical Drugs to OTC Status
  September 14, 2009

• COMMENTARY／Korosho to Embark on Japanese Version of Sentinel Initiative
  September 7, 2009

• COMMENTARY／Wholesalers Need to Analyze Causes of Their Failure
  August 24, 2009

• COMMENTARY／Hisamitsu Aims at Growth by Fusing Its and Noven's Technologies
  August 24, 2009

• COMMENTARY／Permitting MSs to Take MR Cert. Exam Offers New Business Opportunity to Wholesalers
  August 3, 2009

• COMMENTARY／Fair Profits Are Essential to Spread Regenerative Medicine
  August 3, 2009

ページ

• « 先頭
• ‹ Prev
• …
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• …
• Next ›
• 最終 »